Investigación

Tratamiento del cáncer pediátrico

Buscador de publicaciones

Publicaciones

  • Bautista F, Cañete A, Ramírez-Villar GL, Fernández JM, Fuster JL, Diaz de Heredia C, Astigarraga I, García-Ariza M, Rives-Solà S, Dapena JL, Márquez C, Molinés A, Bermúdez MDM, Gallego S, Andrés MDM, Verdu-Amoros J, Hernández C, López M, Català-Temprano A, Lassaletta Á, Cruz-Martínez O, Ramírez M, Lendínez F, Carboné A, Gomez Sirvent J, Tallón M, Acha T, Moreno L, Fernández-Teijeiro A and Sociedad Española de Hematología y Oncología Pediátrica (SEHOP).

    ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

    CLINICAL & TRANSLATIONAL ONCOLOGY . 21(12): 1763-1770. Nº de citas: 4

    [doi:10.1007/s12094-019-02221-9]

  • Munier FL, Beck-Popovic M, Chantada G, Cobrinik D, Kivelä TT, Lohmann D, Maeder P, Moll AC, Carcaboso AM, Moulin A, Schaiquevich P, Bergin C, Dyson PJ, Houghton S, Puccinelli F, Vial Y, Gaillard MC and Stathopoulos C.

    Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"

    PROGRESS IN RETINAL AND EYE RESEARCH . 73: 100764-100764. Nº de citas: 131

    [doi:10.1016/j.preteyeres.2019.05.005]

  • Zaritski A, Castillo H, Kumarasamy M, Peled E, Sverdlov Arzi R, Carcaboso AM and Sosnik A.

    Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression

    ACS APPLIED MATERIALS & INTERFACES . 11(42): 38483-38496. Nº de citas: 22

    [doi:10.1021/acsami.9b12682]

  • Guerreiro Stucklin AS, Ryall S, Fukuoka K, Zapotocky M, Lassaletta A, Li C, Bridge T, Kim B, Arnoldo A, Kowalski PE, Zhong Y, Johnson M, Li C, Ramani AK, Siddaway R, Nobre LF, de Antonellis P, Dunham C, Cheng S, Boué DR, Finlay JL, Coven SL, de Prada I, Perez-Somarriba M, Faria CC, Grotzer MA, Rushing E, Sumerauer D, Zamecnik J, Krskova L, Garcia Ariza M, Cruz-Martínez O, Morales-La Madrid A, Solano P, Terashima K, Nakano Y, Ichimura K, Nagane M, Sakamoto H, Gil-da-Costa MJ, Silva R, Johnston DL, Michaud J, Wilson B, van Landeghem FKH, Oviedo A, McNeely PD, Crooks B, Fried I, Zhukova N, Hansford JR, Nageswararao A, Garzia L, Shago M, Brudno M, Irwin MS, Bartels U, Ramaswamy V, Bouffet E, Taylor MD, Tabori U and Hawkins C.

    Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.

    NATURE COMMUNICATIONS . 10(1): 4343-4343. Nº de citas: 219

    [doi:10.1038/s41467-019-12187-5]

  • Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A, Ma Q, Piunti A, Shimazu Y, Lamano JB, Carcaboso AM, Tian X, Seluanov A, Gorbunova V, Laurie KL, Kondo A, Wadhwani NR, Lulla R, Goldman S, Venneti S, Becher OJ, Zou L, Shilatifard A and Hashizume R.

    Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma

    CLINICAL CANCER RESEARCH . 25(18): 5572-5583. Nº de citas: 57

    [doi:10.1158/1078-0432.CCR-18-3890]

  • Fons NR, Sundaram RK, Breuer GA, Peng S, McLean RL, Kalathil AN, Schmidt MS, Carvalho DM, Mackay A, Jones C, Carcaboso AM, Nazarian J, Berens ME, Brenner C and Bindra RS.

    PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma

    NATURE COMMUNICATIONS . 10: 3790-3790. Nº de citas: 55

    [doi:10.1038/s41467-019-11732-6]

  • Koncar RF, Dey BR, Stanton AJ, Agrawal N, Wassell ML, McCarl LH, Locke AL, Sanders L, Morozova-Vaske O, Myers MI, Hamilton RL, Carcaboso AM, Kohanbash G, Hu B, Amankulor NM, Felker J, Kambhampati M, Nazarian J, Becher OJ, James CD, Hashizume R, Broniscer A, Pollack IF and Agnihotri S.

    Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

    CANCER RESEARCH . 79(16): 4026-4041. Nº de citas: 22

    [doi:10.1158/0008-5472.CAN-18-3521]

  • Aschero MR, Torbidoni A, Sampor C, Laurent V, Zugbi S, Winter U, Lubieniecki F, Alonso D, Schaiquevich P and Chantada G.

    Minimally disseminated disease and outcome in overt orbital retinoblastoma

    PEDIATRIC BLOOD & CANCER . 66(6): . Nº de citas: 6

    [doi:10.1002/pbc.27662]

  • de Rojas T, Clementel E, Giralt J, Cruz-Martínez O, Boterberg T, Kortmann RD, Gaze MN, Moreno L, Janssens GO and SIOP-Europe QUARTET Project and of the EORTC.

    Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.

    EUROPEAN JOURNAL OF CANCER . 114: 36-46. Nº de citas: 10

    [doi:10.1016/j.ejca.2019.03.018]

  • Carvalho D, Taylor KR, Gene-Olaciregui N, Molinari V, Clarke M, Mackay A, Ruddle R, Henley A, Valenti M, Hayes A, Brandon AH, Eccles SA, Raynaud F, Boudhar A, Monje M, Popov S, Moore AS, Mora J, Cruz-Martínez O, Vinci M, Brennan PE, Bullock AN, Carcaboso AM and Jones C.

    ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

    Communications Biology . 2: 156-156. Nº de citas: 69

    [doi:10.1038/s42003-019-0420-8]